Pharmacosmos successfully registers dextran 40 and 70 as excipients in China

Dextran 40 EP & Dextran 70 EP

Dextran 40 EP, reference number F20190000213
Dextran 70 EP, reference number F20190000214
 

Pharmacosmos, a world leader in developing and producing carbohydrates for pharmaceutical applications, has registered Pharmaceutical Quality Dextran 40 EP Monograph and Dextran 70 EP Monograph as excipients in China. The registrations are published on the CFDA website and can be referenced through a letter of access when the Dextran is used as excipients in final products. 

Pharmaceutical Quality Dextran 40 EP and 70 EP are available from Pharmacosmos as excipients for final formulations, drug products, for medical devices, for production of solutions for injection and infusion and much more. 

Pharmacosmos is the only Dextran Manufacturer that has received Certificates from the US FDA and the European Directorate for the Quality of Medicines (EDQM) for the Specific Pharmacopoeial Dextran 40 and 70. 

For additional information on how to obtain a letter of access to the new excipient registration or about the Dextran products, please contact us on dextran@pharmacosmos.com